Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E B Feinberg

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 1, 1992
Treatment of endophthalmitisE B Feinberg
Ophthalmic Surgery|March 1, 1993
Infectious disease risks of fibrin glueE B Feinberg, R Funderburk
Annals of Ophthalmology|February 1, 1989
Diabetes as a risk factor for retinal neovascularization in retinal vein occlusionR L Funderburk, E B Feinberg
Annals of Ophthalmology|August 1, 1992
X-linked pathologic myopiaF M Gregg, E B Feinberg
American Journal of Ophthalmology|January 1, 1972
Cellular immunity in chronic ophthalmic disorders. 3. Leukocyte migration inhibition in uveitisE B Feinberg, B Shore, I H Leopold, et al.
Eye (London, England)|October 2, 2010
Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trialM L Subramanian, G Abedi, S Ness, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 1, 1992
Treatment of endophthalmitisE B Feinberg
Ophthalmic Surgery|March 1, 1993
Infectious disease risks of fibrin glueE B Feinberg, R Funderburk
Annals of Ophthalmology|February 1, 1989
Diabetes as a risk factor for retinal neovascularization in retinal vein occlusionR L Funderburk, E B Feinberg
Annals of Ophthalmology|August 1, 1992
X-linked pathologic myopiaF M Gregg, E B Feinberg
American Journal of Ophthalmology|January 1, 1972
Cellular immunity in chronic ophthalmic disorders. 3. Leukocyte migration inhibition in uveitisE B Feinberg, B Shore, I H Leopold, et al.
Eye (London, England)|October 2, 2010
Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trialM L Subramanian, G Abedi, S Ness, et al.
Pageof 1